Filing Flows

Filing Flows › Biogen (BIIB) › Recalls, complaints & regulation

Biogen (BIIB): clinical trials and Federal Register

Biogen (BIIB) beyond its filings: 2 Federal Register documents in a year; 42 active clinical trials.

Biogen's latest quarter

Biogen, Q3 2026: revenue $2.8B (+11% year over year), operating margin -0.3%, net loss $20.6M, operating cash flow $641M. The chart follows the revenue to costs, profit and cash.

Questions

How many clinical trials does Biogen have?

42 active studies on ClinicalTrials.gov, 17 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.